Exelixis puts fat wallet to work with Cybrexa, Sairopa deals - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 68%

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

$EXEL's fat wallet beefs up its cancer drug pipeline

Exelixis Inc. President and CEOwarned that the company wasn't going to just sit on its cancer drug franchise, not with $2 billion in cash, equivalents and investments.

In the Sairopa deal, Exelixis will pay $40 million upfront and $70 million in near-term milestones for an exclusive, worldwide license to develop and sell Sairopa's ADU-1805. The drug is a monoclonal antibody targeting a protein — called signal regulatory protein alpha, or SIRPa — that protects cancer-associated proteins from being detected by the immune system's T cells and helps block the ability to clear tumor cells.

The moves were announced as Exelixis reported its third-quarter financials that showed the company with a $212.4 million profit through the first nine months of the year on revenue of nearly $1.19 billion.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in UK

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

An inside look into multi-family housing and the real estate market today - CEO SpotlightShakti C'Ganti, CEO, Ashland Greene Capital joins KRLD's David Johnson for this episode of CEO Spotlight.
Source: KRLD - 🏆 75. / 68 Read more »

Exelixis puts fat wallet to work with Cybrexa, Sairopa deals - San Francisco Business TimesPresident and CEO Michael Morrissey said the deals tap the company's balance sheet and share risks with its partners.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »

Ryan Rogers, grandson of Mary Kay Ash, appointed to CEO of cosmetic company - Dallas Business JournalRyan Rogers is following in the footsteps of his grandmother and company founder Mary Kay Ash and father Richard R. Rogers.
Source: DallasBizNews - 🏆 525. / 51 Read more »